Prot# SSEB: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa

Project: Research project

Project Details

StatusFinished
Effective start/end date9/20/06 → 1/1/12

Funding

  • RegeneRx Biopharmaceuticals, Inc. (SSEB)